Genetic Analysis AS (NGM:GEAN)
Sweden flag Sweden · Delayed Price · Currency is SEK · Price in NOK
0.6700
-0.0250 (-3.60%)
At close: Apr 16, 2025

Genetic Analysis AS Company Description

Genetic Analysis AS, a science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.

It offers GA-map, a platform for the analysis of the human gut microbiota; GA-map Dysbiosis Test that detects and characterizes dysbiosis; and GA-map Analyzer, a cloud-based software solution.

The company also provides GA-map Discovery, a tool to search biomarkers and validate research findings or transfer the findings to a ready-to-use routine testing platform; GA-map Sample Collection Kit used for collection, transport, and storage of fecal specimens for nucleic acid analyses; and GA-map Covid-19 Fecal Test, a non-invasive test with an easy-to-use home sampling procedure.

Further, it offers laboratory services; and bioinformatic analysis services. The company develops rapid microbiome-based PCR test.

Genetic Analysis AS was founded in 2008 and is headquartered in Oslo, Norway.

Genetic Analysis AS
Country Norway
Founded 2008
Industry Diagnostics & Research
Sector Healthcare
Employees 21
CEO Ronny Hermansen

Contact Details

Address:
Ulvenveien 80B
Oslo, 0581
Norway
Phone 47 48 32 16 10
Website genetic-analysis.com

Stock Details

Ticker Symbol GEAN
Exchange Nordic Growth Market
Fiscal Year January - December
Reporting Currency NOK
SIC Code 2835

Key Executives

Name Position
Ronny Hermansen MSc Chief Executive Officer
Lars Tiller Head of Operations
Christina Casen Senior Vice President of Clinical and Medical Affairs
Kari Furu Head of Commercial